Company Australian Clinical Labs Limited

Equities

ACL

AU0000148496

Healthcare Facilities & Services

Market Closed - Australian S.E. 02:10:46 2024-04-30 am EDT 5-day change 1st Jan Change
2.43 AUD -0.82% Intraday chart for Australian Clinical Labs Limited -0.41% -15.92%

Business Summary

Australian Clinical Labs Limited is a private provider of pathology services. Its laboratories perform a range of pathology tests each year for a range of clients, including doctors, specialists, patients, hospitals, and corporate clients. It performs a range of services for doctors, patients, and corporate clients, including routine pathology tests, advanced molecular genetics testing, harmony NIPT and first trimester screening, genetic carrier screening, chemical pathology, histopathology and cytopathology, hematology, allergy and immunology, serology and microbiology, infectious molecular testing, cardiac testing services, functional pathology, veterinary pathology, and commercial drug and alcohol testing. Its specialist services include molecular cancer services, obstetrics and gynecology, pharmacogenetic testing, gastroenterology, and hospital services. It has operations in Victoria, New South Wales, Western Australia, South Australia, Queensland, and the Northern Territory.

Number of employees: 5,115

Sales per Business

AUD in Million2022Weight2023Weight Delta
Pathology
97.2 %
977 98.1 % 678 97.2 % -30.60%
Clinic
2.1 %
13 1.3 % 14 2.1 % +12.86%
Other
0.6 %
6 0.6 % 4 0.6 % -27.59%
Rental
0.1 %
1 0.1 % 1 0.1 % +34.88%

Sales per region

AUD in Million2022Weight2023Weight Delta
Australia
100.0 %
996 100.0 % 697 100.0 % -29.99%

Managers

Managers TitleAgeSince
Chief Executive Officer - 14-12-31
Director of Finance/CFO - 14-12-31
Chief Tech/Sci/R&D Officer - 08-12-31
Chief Tech/Sci/R&D Officer - 14-12-31
Chief Operating Officer - 15-12-31
Sales & Marketing - 14-12-31
Corporate Officer/Principal - 14-12-31
Corporate Officer/Principal - 17-12-31
Corporate Officer/Principal - 10-12-31
Corporate Secretary - 21-04-27

Members of the board

Members of the board TitleAgeSince
Chairman 56 14-12-31
Director/Board Member 67 21-04-27
Director/Board Member - 23-08-22
Director/Board Member - 21-04-27
Director/Board Member - 18-03-31
Director/Board Member 61 21-04-27
Chief Executive Officer - 14-12-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 201,834,015 112,579,972 ( 55.78 %) 1,330,743 ( 0.6593 %) 55.78 %

Shareholders

NameEquities%Valuation
Crescent Capital Partners Ltd.
30.12 %
60,793,029 30.12 % 107 M $
Ethical Partners Funds Management Pty Ltd.
9.719 %
19,616,540 9.719 % 34 M $
Superannuation Funds Management Corp. of South Australia
7.088 %
14,306,947 7.088 % 25 M $
Australian Ethical Investments Ltd. (Investment Management)
6.090 %
12,291,800 6.090 % 22 M $
Regal Funds Management Pty Ltd.
4.990 %
10,071,517 4.990 % 18 M $
Hearts Trust
4.714 %
9,514,668 4.714 % 17 M $
River Capital Pty Ltd.
3.816 %
7,702,809 3.816 % 14 M $
Investors Mutual Ltd.
2.495 %
5,035,608 2.495 % 9 M $
First Sentier Investors (Australia) IM Ltd.
1.929 %
3,893,456 1.929 % 7 M $
Roc Capital Pty Ltd.
1.918 %
3,870,820 1.918 % 7 M $

Holdings

NameEquities%Valuation
36,230,451 4.99% 31,318,689 $
2,318,243 1.15% 4,068,424 $

Company contact information

Australian Clinical Labs Ltd.

1868-1892 Dandenong Road

3168, Clayton

+

http://www.clinicallabs.com.au
address Australian Clinical Labs Limited(ACL)
  1. Stock Market
  2. Equities
  3. ACL Stock
  4. Company Australian Clinical Labs Limited